Genpharmasec Reports Strong Sales Growth Amid Declining Profitability in May 2025 Results

May 22 2025 10:32 AM IST
share
Share Via
Genpharmasec has reported its financial results for the quarter ending March 2025, showing significant growth in net sales at Rs 14.01 crore, the highest in five quarters. However, the company faces challenges with declining profit before tax and profit after tax, alongside a reduced operating profit margin.
Genpharmasec, a microcap company in the Trading & Distributors industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 21, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting recent performance metrics.

On a positive note, Genpharmasec achieved net sales of Rs 14.01 crore, marking a significant growth compared to the average net sales of the previous four quarters, which stood at Rs 7.48 crore. This figure represents the highest quarterly sales in the last five quarters, suggesting a favorable near-term sales trend.

Conversely, the financial results also highlight challenges for Genpharmasec. The profit before tax less other income (PBT) recorded a substantial decline, reaching Rs -1.37 crore, which is the lowest in the last five quarters. Similarly, profit after tax (PAT) fell to Rs -0.27 crore, indicating a negative trend in profitability. The operating profit margin also reached its lowest point at -7.14%, reflecting a decline in operational efficiency.

Overall, the financial results for Genpharmasec reveal a complex landscape of growth in sales juxtaposed with significant challenges in profitability and operational performance.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Genpharmasec falling/rising?
Dec 05 2025 12:47 AM IST
share
Share Via
Why is Genpharmasec falling/rising?
Nov 13 2025 09:42 PM IST
share
Share Via
Why is Genpharmasec falling/rising?
Nov 11 2025 09:34 PM IST
share
Share Via